Scientists led by Martin Widschwendter (EUTOPS Institute) are developing methods for the early detection of women-specific cancers. With the help of the WID®-tests, epigenetic methods can detect already existing diseases, e.g., endometrial cancer using the WID®-easy-Test. But they also show who has an increased risk of developing cancer in the future.